Triumeq

Product NDC

50090-1606

11-digit product format

500901606

Labeler code

50090

Product ID

50090-1606_37a43c59-6382-40e8-9a5b-cc9d0e01122d

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

abacavir sulfate, dolutegravir sodium, lamivudine

Dosage form

TABLET, FILM COATED

Route

ORAL

Labeler

A-S Medication Solutions

Application

NDA205551

Marketing category

NDA

Marketing start

2014-08-22

Marketing end

0000-00-00

Substance

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Active strength

600 mg/1; mg/1; mg/1

Pharmacologic classes

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]

NDC exclude flag

No

Listing certified through

2020-12-31

Current FDA listing

Historical FDA.report record